Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,338,015
-
Share change
-
-248,727
-
Total reported value
-
$34,717,043
-
Price per share
-
$8.03
-
Number of holders
-
30
-
Value change
-
-$2,541,126
-
Number of buys
-
15
-
Number of sells
-
17
Institutional Holders of ARGOS THERAPEUTICS INC - COM (ARGS) as of Q2 2014
As of 30 Jun 2014,
ARGOS THERAPEUTICS INC - COM (ARGS) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,338,015 shares.
The largest 10 holders included
WASATCH ADVISORS INC, MARXE AUSTIN W & GREENHOUSE DAVID M, CAISSE DE DEPOT ET PLACEMENT DU QUEBEC, WALL STREET ASSOCIATES, ALTRINSIC GLOBAL ADVISORS LLC, Pine River Capital Management L.P., Alyeska Investment Group, L.P., VANGUARD GROUP INC, EDELMAN FINANCIAL GROUP INC., and NORTHERN TRUST CORP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.